| Literature DB >> 25012491 |
Katrin Gottlieb, Christoph Albermann, Georg A Sprenger.
Abstract
BACKGROUND: For the production of L-phenylalanine (L-Phe), two molecules of phosphoenolpyruvate (PEP) and one molecule erythrose-4-phosphate (E4P) are necessary. PEP stems from glycolysis whereas E4P is formed in the pentose phosphate pathway (PPP). Glucose, commonly used for L-Phe production with recombinant E. coli, is taken up via the PEP-dependent phosphotransferase system which delivers glucose-6-phosphate (G6P). G6P enters either glycolysis or the PPP. In contrast, glycerol is phosphorylated by an ATP-dependent glycerol kinase (GlpK) thus saving one PEP. However, two gluconeogenic reactions (fructose-1,6-bisphosphate aldolase, fructose-1,6-bisphosphatase, FBPase) are necessary for growth and provision of E4P. Glycerol has become an important carbon source for biotechnology and reports on production of L-Phe from glycerol are available. However, the influence of FBPase and transketolase reactions on L-Phe production has not been reported.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25012491 PMCID: PMC4227036 DOI: 10.1186/s12934-014-0096-1
Source DB: PubMed Journal: Microb Cell Fact ISSN: 1475-2859 Impact factor: 5.328
Figure 1Pathway and carbon flux from glycerol to L-phenylalanine. Scheme of carbon flux to L-Phe based on glycerol. Broken arrows indicate an incomplete presentation of the metabolic pathway. The reactions catalyzed by glycerol kinase (GlpK) transketolase (TktA) and fructose-1,6-bisphosphatase (GlpX) are highlighted in bold. Numerics indicate the numbers of molecules from the aforementioned compounds. Based on 1000 molecules of glycerol, 298.7 molecules of L-Phe can be formed.
Strains and plasmids used in this study
| LJ110 | Wildtype W3110 (F−, λ−, IN ( | [[ |
| BW25113 | [[ | |
| ∆ | ||
| XL1-Blue | (Stratagene, La Jolla, USA) | |
| F4 | LJ 110 Δ ( | [[ |
| F144 | LJ 110 Δ | J.Bongaerts, unpubl. [[ |
| FUS4 | LJ110 Δ ( | G. A. Sprenger and N. Trachtmann, unpubl. |
| BW25113 Δ | BW25113 Ara+ Δ | N. Trachtmann and G.A. Sprenger, [[ |
| BW25113 Δ | BW25113 Ara+ Δ | N. Trachtmann, [[ |
| BW25113 | BW25113 Δ | This work |
| BW25113 | BW25113 Δ | This work |
| LJ110 Δ | LJ110 Δ | This work |
| LJ110 Δ | LJ110 Δ | This work |
| LJ110 Δ | LJ110 Δ | This work |
| BW25113 | BW25113 Δ | This work |
| FUS4.2 | FUS4 Δ | This work |
| FUS4.2-1 | FUS4 Δ | This work |
| FUS4.5 | FUS4 Δ | This work |
| FUS4.6 | FUS4 Δ | This work |
| FUS4.6-2 | FUS4 Δ | This work |
| FUS4.7 | FUS4 Δ | This work |
| pKD46 | λ Red disruption system (γ, β, exo under control of | [[ |
| pCP20 | [[ | |
| pCO1kanFRT | Ampr Kmr; Kanamycin resistance gene flanked by FRT sites | U. Degner and G.A. Sprenger, unpubl. [[ |
| pCO1catFRT | Apr Cmr; chloramphenicol resistance gene flanked by FRT sites | U. Degner and G.A. Sprenger, [[ |
| pJF119EH | Ptac, RBS, AmpR, | [[ |
| pF81 | Ptac:: | [[ |
| pKUS3 | 1,5 kb | This work |
| pKUS3-1 | pKUS3 with Quikchange | This work, according to [[ |
| pKUS10 | pKUS3 with a chloramphenicol-resistance cassette in | This work |
| pKUS13 | 1,5 kb | This work |
| pKUS14 | pKUS13 with a chloramphenicol-resistance cassette in | This work |
Figure 2In order to compare (glucose, glycerol, crude glycerol) and pOon L-phenylalanine productivity in fed-batch cultivations. Strain FUS4/pF81 was cultivated in fed-batch mode under different conditions. (a) with glycerol at 60%, (b) or 20% O2 saturation, (c) with glucose (60% O2), or (d) with crude glycerol (20% O2) as carbon source. The arrows indicate the time point when IPTG was added for induction. Data for growth rate, carbon yield, space-time-yield, and absolute concentration of L-Phe are listed in Table 2. All fermentations were conducted in MM as described in Materials and methods and were performed two times independently. The mean values are given in Table 2. Diamonds indicate OD600 values, triangles indicate L-Phe concentration [g l−1].
Comparison of the results from the fed-batch fermentations with FUS4/pF81 and its derivatives
| | (μ [h−1]) | [mM] ([%]) | [g l−1 h−1] ([%]) | [g l−1] ([%]) | [mM] | [mM] |
| FUS4/pF81 | 0.27 ± 0.01 | 0.18 ± 0.02 (100) | 0.21 ± 0.02 (100) | 7.9 ± 0.2 (100) | 30.7 ± 10.5 | 9.5 ± 5.5 |
| FUS4/pF81 (20% O2) | 0.26 ± 0.01 | 0.26 ± 0.03 (144.4) | 0.26 ± 0.01 (123,8) | 9.4 ± 0.7 (119,0) | n.d.* | n.d. |
| FUS4/pF81 (Glucose) | 0.49 ± 0.01 | 0.19 ± 0.02 (105.6) | 0.13 ± 0.01 (61.9) | 5.5 ± 1.3 (69.6) | 15.4 ± 4.7 | 3.0 ± 0.7 |
| FUS4/pF81 (crude glycerol, 20% O2) | 0.32 ± 0.01 | 0.23 ± 0.05 (127.8) | 0.22 ± 0.05 (104.8) | 10.0 ± 0.9 (126.6) | 46.8 ± 1.5 | 24.9 ± 6.8 |
| FUS4.5/pF81 | 0.28 ± 0.02 | 0.21 ± 0.04 (116.7) | 0.23 ± 0.01 (109.5) | 9.7 ± 0.8 (124.0) | 69.1 ± 9.5 | 21.9 ± 3.7 |
| FUS4.6/pF81 | 0.29 ± 0.03 | 0.20 ± 0.01 (111.1) | 0.25 ± 0.02 (119.0) | 7.3 ± 0.5 (92.4) | 21.1 ± 1.4 | 3.2 ± 0.4 |
| FUS4.7/pF81 | 0.24 ± 0.01 | 0.26 ± 0.06 (144.4) | 0.37 ± 0.01 (180.5) | 10.1 ± 0.2 (127.8) | 31.3 ± 5.0 | 7.9 ± 3.8 |
n.d. not detectable, *lactate was not detectable as long as the glycerol concentration stayed below 5 g/l.
All fed-batch fermentations were conducted two times independently in MM in a 3.6 l bioreactor (as described in Materials and methods). If not stated otherwise, (in brackets) pure glycerol was used as carbon source and oxygen saturation was at 60%. The values represent the mean value and the standard deviation.
Enzyme activities of fructose-1,6-bisphosphatase II and glycerol kinase in the crude extract
| | | 0 mM FBP | 10 mM FBP |
| FUS4 | 0.53 ± 0.21 | - | - |
| FUS4.6 | 0.97 ± 0.24 | - | - |
| DH5α pJF119 | 0.42 ± 0.22 | 1.5 ± 0.3 | 0.2 ± 0.1 |
| DH5α pKUS13 | 3.05 ± 0.62 | - | - |
| DH5α pKUS3 | - | 52.7 ± 4.1 | 11.2 ± 0.9 |
| DH5α pKUS3-1 | - | 64.4 ± 3.6 | 43.3 ± 3.8 |
Cells were grown and induced with IPTG as described in Materials and methods. FBPase and glycerol kinase activity was measured in cell-free extracts. DH5α/pKUS13 (carrying gene glpX) was compared to the control, DH5α/pJF119EH (empty vector). DH5α/pKUS3 (carrying gene glpK) and DH5α/pKUS3-1 (carrying gene glpK) were also compared to the control, DH5α/pJF119EH. After chromosomal integration of glpX FBPase activity was measured in the cell-free extract of the resulting strain FUS4.6 and as control in the parent strain, FUS4. FBPase activity was measured by quantifying phosphate release using a malachite green/ammonium molybdate solution and glycerol kinase activity was measured using a pyruvate kinase and lactate dehydrogenase coupled assay as described in Materials and methods [[50]].
The values represent the mean value and the standard deviation.
Figure 3Effect of additional copies oforon batch growth and L-phenylalanine production. Strains were grown in MM + 0.5% glycerol in batch cultures as described in Materials and methods. Cultures were analyzed regarding (a) cell growth of FUS4/pF81 (open squares), FUS4.2/pF81 (open circles, additional chromosomal copy of glpK), and FUS4.2-1/pF81 (open triangles, additional chromosomal copy of glpK), and L-Phe production in [g l−1] of FUS4/pF81 (filled squares, full line), FUS4.2/pF81(closed circles, full line), and FUS4.2-1/pF81 (filled triangles, full line). The dotted line shows glycerol consumption of FUS4/pF81 (filled squares), FUS4.2/pF81 (closed diamonds), and FUS4.2-1/pF81 (filled triangles). (b) Growth rates were determined during the time period of 1–7 h in (a).
Figure 4Fed-batch cultivations of FUS4/pF81 mutants with putatively increased flux through the PPP. Fed-batch fermentations were conducted in MM with pure glycerol as carbon source. Cell growth (diamonds) and L-Phe concentrations [g l−1] (squares) are shown in the diagrams a-c. The arrows indicate induction with IPTG. Data for carbon yield, space-time-yield and absolute concentration of L-Phe are listed in Table 2. All fermentations were performed two times independently, one typical growth curve is presented. (a) FUS4.6/pF81 (additional gene copy of glpX), (b) FUS4.5/pF81 (additional gene copy of tktA), (c) FUS4.7/pF81 (additional gene copy of tktA and glpX).
Oligonucleotides used in this study
| 5′- | |
| 5′- | |
| 5′- | |
| 5′- | |
| 5′-GCTTTCGTTACATTTTGCAGCTGTACG-3′ | |
| 5′-CCGTCACAGGTAGGCGCGCC-3′ | |
| 5′-TTTT | |
| 5′-TTTT | |
| 5′-GCTGT | |
| 5′-CCGGATGCGGCATAA | |
| 5′-GTATACGGTCAGACTAATATTGGCGACAAAGGCGGCAC-3′ | |
| 5′-GTGCCGCCTTTGTCGCCAATATTAGTCTGACCGTATAC-3′ |
Sequence homologous to chromosomal integration location is shown in italics, bold letters indicate engineered restriction sites.